ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,342Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 3035

$1.99M Total Retail Price of All Prescriptions

Rank: 39 out of 3035

1,948 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

1% of this provider’s 1,948 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 1,948 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL SUCCINATE 976 829 245 1 13
METFORMIN HCL 968 744 305 2 9
PRAVASTATIN SODIUM 949 760 278 3 11
LEVOTHYROXINE SODIUM 940 794 209 4 1
AMLODIPINE BESYLATE 853 702 257 5 2
LISINOPRIL 840 673 266 6 3
SIMVASTATIN 795 650 230 7 4
NEXIUM 733 612 202 8 20
HYDROCODONE-ACETAMINOPHEN 695 518 234 S3 9 5
LOSARTAN POTASSIUM 659 570 197 10 14
ATORVASTATIN CALCIUM 648 549 210 11 6
GABAPENTIN 522 410 174 12 12
FUROSEMIDE 507 437 141 13 7
JANUVIA 473 422 109 14 49
TRAZODONE HCL 443 371 121 15 40
OMEPRAZOLE 434 353 136 16 8
TRAMADOL HCL 432 373 185 17 17
HYDROCHLOROTHIAZIDE 401 350 125 18 16
ENALAPRIL MALEATE 354 294 91 19 60
SERTRALINE HCL 345 317 112 20 26
TAMSULOSIN HCL 342 314 91 21 28
CLOPIDOGREL 332 299 86 22 18
GLIPIZIDE 325 266 102 23 50
AZITHROMYCIN 313 235 260 24 46
CRESTOR 296 248 98 25 22
MELOXICAM 294 265 158 26 35
TRAMADOL HCL-ACETAMINOPHEN 274 200 109 27 96
PREDNISONE 272 229 196 28 45
LANTUS 269 204 70 29 56
DIOVAN 257 228 74 30 36
HYDRALAZINE HCL 250 219 70 31 59
LEVEMIR FLEXPEN 244 202 65 32 117
METOPROLOL TARTRATE 228 159 81 33 10
PIOGLITAZONE HCL 225 178 86 R 34 86
VALSARTAN-HYDROCHLOROTHIAZIDE 225 196 55 34 67
VOLTAREN 220 202 128 36 112
LANTUS SOLOSTAR 213 170 63 37 73
WARFARIN SODIUM 187 174 39 38 25
LEVOFLOXACIN 185 143 155 39 55
ALENDRONATE SODIUM 183 172 65 40 30
BD ULTRA-FINE PEN NEEDLE 177 131 76 41 104
ZOLPIDEM TARTRATE 171 106 50 42 23
DONEPEZIL HCL 165 150 57 43 31
MIRTAZAPINE 157 142 48 44 62
ISOSORBIDE MONONITRATE ER 153 129 36 45 61
NAMENDA 150 130 38 46 27
TERBINAFINE HCL 149 119 88 47 302
PAROXETINE HCL 148 111 50 48 80
CARVEDILOL 147 106 43 49 21
ATENOLOL 146 117 42 50 32
LOVAZA 145 97 52 51 95
JANUMET 145 101 39 51 144
LYRICA 143 106 31 53 63
MECLIZINE HCL 137 113 84 54 126
PANTOPRAZOLE SODIUM 136 124 38 55 24
CIPROFLOXACIN HCL 135 107 121 56 51
NAPROXEN 133 95 70 57 84
EXFORGE 123 112 27 58 149
AMLODIPINE BESYLATE-BENAZEPRIL 122 111 35 59 71
LOSARTAN-HYDROCHLOROTHIAZIDE 114 95 35 60 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 81 34 61 34
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 80 91 62 88
RANITIDINE HCL 104 99* 40 62 64
ESCITALOPRAM OXALATE 103 62 31 64 42
GLIMEPIRIDE 103 75 29 64 37
POTASSIUM CHLORIDE 103 85 34 64 15
INSULIN SYRINGE* 101 60 42 67 186
CLONAZEPAM 100 43 32 B 68 58
BENAZEPRIL HCL 100 86 26 68 85
LEVEMIR 99 77 24 70 133
GLIPIZIDE XL 99 81 32 70 195
VESICARE 95 79 34 72 108
ALPRAZOLAM 85 51 34 B 73 19
AMOX TR-POTASSIUM CLAVULANATE 84 64 77 74 102
DIGOXIN 80 60 18 75 147
GLIPIZIDE ER 79 61 42 76 115
FLUOXETINE HCL 79 40 20 76 77
SPIRIVA 77 72* 29 78 78
ROPINIROLE HCL 76 58 18 79 109
ACARBOSE 74 57 23 80 298
CYMBALTA 74 49 29 80 39
GLIPIZIDE-METFORMIN 73 68* 14 82 173
FAMOTIDINE* 73 68* 24 82 76
BACLOFEN 73 56 35 82 107
GLYBURIDE-METFORMIN HCL 72 51 27 R 85 101
LIDODERM 71 66* 43 86 125
GEMFIBROZIL 68 52 23 87 111
AVODART 68 56 20 87 145
MONTELUKAST SODIUM 68 52 24 87 44
TRIAMCINOLONE ACETONIDE 67 62* 42 90 136
CEPHALEXIN 67 62* 59 90 122
LOVASTATIN 67 49 15 90 52
ZETIA 66 61* 25 93 70
ALLOPURINOL 64 43 23 94 38
FINASTERIDE 64 59* 17 94 90
PROAIR HFA 63 58* 40 96 65
BENICAR 63 58* 21 96 119
LACTULOSE 62 57* 38 98 114
PROPRANOLOL HCL 60 41 22 99 151
LEVETIRACETAM 60 55* 12 99 99
CEFDINIR 59 54* 55 101 174
BUPROPION XL 58 43 25 102 180
DIGOX 57 52* 18 103 100
FLUTICASONE PROPIONATE 55 50* 33 104 33
SPIRONOLACTONE 53 48* 15 105 69
OXYBUTYNIN CHLORIDE 52 <11 <11 106 131
ONGLYZA 51 46* 15 107 218
LABETALOL HCL 51 37 12 107 170
AMIODARONE HCL 50 45* 16 109 152
MUPIROCIN* 50 45* 45 109 198
XARELTO 50 50 11 109 169
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.